Benefits of a 6-month, Individualized, Hybrid, "Real-life" Adapted Physical Activity Program on the Quality of Life of Patients Treated for Multiple Myeloma

Condition(s) studied

Investigational drug(s) / intervention(s)

Adapted physical activity: the intervention is a "real life"6 months adapted physical activity program which is individualised and hybrid (presential and distancial) . It includes a session in presential (at hospital) every 2 weeks for the first 3 months then once a month and 3 sessions par week for 6 months at home.

Study summary

The goal of this clinical trial is to evaluate the effect of a long-term, individualized, hybrid adapted physical activity program on the quality of life of patients with multiple myeloma. The main question it aims to answer are :

Does this logn term, individualized and hybrid adapted physical activity program improve quality of life in multiple myeloma patient ? What are the effects of this program on effort tolerance, pain, muscular mass, osteolytic lesions, tolerance to treatment, response to treatment? If there is a comparison group: Researchers will compare \[arm information\] to see if \[insert effects\].

Participants will be randomised in 2 groups.

* control group: patients will receive only advices about physical activities benefit
* interventional group: This group will be offered a program of adapted physical activities mixing sessions at home (remote) and sessions at the hospital (in person).

Eligibility

Primary outcome measure(s)

• compare EORTC-QLQ-C30 summary score at 6 months between both groups — 6 months post inclusion
  EORTC-QLQ-C30 questionnaire will be given to participant at inclusion and at 6 months, score will be calculated

Trial sites (2)

More Centre Hospitalier Metropole Savoie trials in France

Other trials for the same condition